Actinogen Medical Statistics
Total Valuation
ATGGF has a market cap or net worth of 52.26 million. The enterprise value is 37.77 million.
| Market Cap | 52.26M |
| Enterprise Value | 37.77M |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 3.13B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +35.04% |
| Shares Change (QoQ) | +27.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.36B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.36 |
| PB Ratio | 3.52 |
| P/TBV Ratio | 3.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.32 |
| EV / Sales | 6.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.99 |
Financial Position
The company has a current ratio of 18.76, with a Debt / Equity ratio of 0.01.
| Current Ratio | 18.76 |
| Quick Ratio | 18.73 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -296.71 |
Financial Efficiency
Return on equity (ROE) is -53.73% and return on invested capital (ROIC) is -34.33%.
| Return on Equity (ROE) | -53.73% |
| Return on Assets (ROA) | -31.46% |
| Return on Invested Capital (ROIC) | -34.33% |
| Return on Capital Employed (ROCE) | -41.19% |
| Revenue Per Employee | 930,593 |
| Profits Per Employee | -995,998 |
| Employee Count | 6 |
| Asset Turnover | 0.46 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is 1.13, so ATGGF's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +33.33% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 0.58 |
| Average Volume (20 Days) | 3,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ATGGF had revenue of 5.58 million and -5.98 million in losses. Loss per share was -0.00.
| Revenue | 5.58M |
| Gross Profit | 5.58M |
| Operating Income | -6.17M |
| Pretax Income | -5.98M |
| Net Income | -5.98M |
| EBITDA | -5.97M |
| EBIT | -6.17M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 14.15 million in cash and 179,247 in debt, giving a net cash position of 13.97 million.
| Cash & Cash Equivalents | 14.15M |
| Total Debt | 179,247 |
| Net Cash | 13.97M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 14.83M |
| Book Value Per Share | 0.00 |
| Working Capital | 13.59M |
Cash Flow
In the last 12 months, operating cash flow was -5.40 million and capital expenditures -5,586, giving a free cash flow of -5.40 million.
| Operating Cash Flow | -5.40M |
| Capital Expenditures | -5,586 |
| Free Cash Flow | -5.40M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -110.44% and -107.03%.
| Gross Margin | 100.00% |
| Operating Margin | -110.44% |
| Pretax Margin | -107.03% |
| Profit Margin | -107.03% |
| EBITDA Margin | -106.83% |
| EBIT Margin | -110.44% |
| FCF Margin | n/a |
Dividends & Yields
ATGGF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.04% |
| Shareholder Yield | -35.04% |
| Earnings Yield | -11.44% |
| FCF Yield | -10.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ATGGF has an Altman Z-Score of 32.7.
| Altman Z-Score | 32.7 |
| Piotroski F-Score | n/a |